Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07461493 · ClinicalTrials.gov registry record
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
A clinical trial of Cancer and Cancer Comorbidities, sponsored by National Minority Quality Forum.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 2
- Study locations
NCT07461493 is a study of Cancer and Cancer Comorbidities that is actively recruiting participants, run by National Minority Quality Forum. The registered enrollment target is 100,000 participants, above the 3,329-participant average among 615 other Cancer trials with a reported enrollment target (2904% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT07461493, a study of Cancer and Cancer Comorbidities, is actively recruiting participants, sponsored by National Minority Quality Forum.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer. The study seeks to address: •Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations. Participants will: * Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study. * Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history. * Allow relevant health information from their electronic health records (EHR) to be collected and reviewed. * Provide blood, saliva, and stool samples for research purposes. * Enter a long-term follow-up period for an additional five years.
Conditions Studied
Study Locations (2)
Michigan
- Life in 3D Health Services - Flint
Texas
- Grace Clinic - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2039-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07461493
The ClinicalTrials.gov registry entry for NCT07461493 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,329-participant average among 615 other Cancer trials with a reported enrollment target (2904% higher). The listed sponsor is National Minority Quality Forum, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT07461493 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Texas.
Frequently Asked Questions
What is clinical trial NCT07461493 about?
NCT07461493 is a clinical study titled "The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care". The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support...
What is the current status of trial NCT07461493?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2025-03-11. Estimated completion is 2039-03.
What conditions does trial NCT07461493 study?
This clinical trial studies the following conditions: Cancer, Cancer Comorbidities.
Who is sponsoring clinical trial NCT07461493?
This trial is sponsored by National Minority Quality Forum, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07461493 being conducted?
This trial has 2 study locations across Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.